FLOR3 Gene Polymorphism in Predicting Outcomes of Tyrosine Kinase Inhibitor(TKI)Stopping in Chronic Myeloid Leukemia
Condition(s):Folate; CML; Treatment-free RemissionLast Updated:January 3, 2022Unknown status
Hide Studies Not Open or Pending
Condition(s):Folate; CML; Treatment-free RemissionLast Updated:January 3, 2022Unknown status
Condition(s):Chronic Myeloid LeukemiaLast Updated:April 8, 2016Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:December 3, 2019Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:August 3, 2007Terminated
Condition(s):Chronic Myelogenous LeukemiaLast Updated:February 29, 2024Recruiting
Condition(s):Philadelphia Positive (Ph+) Chronic Myeloid LeukemiaLast Updated:December 10, 2019Terminated
Condition(s):Chronic Myeloid LeukemiaLast Updated:December 9, 2020Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:January 13, 2014Unknown status
Condition(s):Chronic Myelogenous LeukemiaLast Updated:February 28, 2024Active, not recruiting
Condition(s):Chronic Myelogenous LeukemiaLast Updated:September 6, 2018Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.